Blood test for ALS diagnosis
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at a blood test to help doctors diagnose ALS (Lou Gehrig's disease). It tests a protein called neurofilaments that may show nerve damage. The study is for people suspected of having ALS, and the blood sample is taken as part of normal care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have symptoms that make your doctor suspect ALS
- You are able to have a blood draw (part of regular care)
- You have not had a recent stroke
- You are not pregnant or breastfeeding
- You can understand and sign a consent form in French
- You are not under legal protection or detention
- You are not currently in another research study with an exclusion period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for new ways to detect and understand ALS by analyzing tiny nerve and blood markers. It may help find better treatments for ALS and related nerve diseases.
This study collects blood, skin, and urine samples from people with ALS to build a cell bank and look for biomarkers—natural signs that might help track the disease or guide future treatments. It doesn't test a new drug, but it helps researchers learn more about ALS.
This study looks for early signs of ALS in people with genetic risk, healthy controls, and people with early symptoms. It aims to find markers that could help diagnose ALS sooner.
This study is looking for biological markers in the blood that can help monitor how ALS progresses and potentially detect it earlier. By participating, you may help improve future diagnosis and care for ALS patients.
This study looks at platelets (tiny blood cells that help clotting) in people with ALS to find a way to diagnose the disease earlier. If you've been recently diagnosed with ALS or another motor neuron disease, your blood sample could help researchers develop a simple test.
This trial collects blood and spinal fluid samples from people being checked for ALS. The goal is to find clues (biomarkers) in tiny particles from nerve cells that could help doctors better understand and diagnose ALS.
Hear when a new Neurodegenerative Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.